Semler Scientific (NASDAQ:SMLR – Get Free Report) is expected to post its quarterly earnings results before the market opens on Tuesday, March 4th. Analysts expect Semler Scientific to post earnings of $0.20 per share and revenue of $12.00 million for the quarter. Investors interested in listening to the company’s conference call can do so using this link.
Semler Scientific (NASDAQ:SMLR – Get Free Report) last issued its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $3.21. The company had revenue of $12.41 million for the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%.
Semler Scientific Trading Down 7.0 %
Semler Scientific stock opened at $44.38 on Tuesday. The company has a fifty day simple moving average of $55.82 and a 200 day simple moving average of $43.06. The company has a market cap of $411.27 million, a P/E ratio of 9.04 and a beta of 1.17. Semler Scientific has a 1-year low of $20.88 and a 1-year high of $81.56.
Analysts Set New Price Targets
Check Out Our Latest Stock Report on SMLR
About Semler Scientific
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.
Read More
- Five stocks we like better than Semler Scientific
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Finding Hidden Gems: Unconventional Penny Stock Investing
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Price Targets on NVIDIA Rise in Front of Earnings
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.